Speech-Language Pathologists in Scottsville, NY Accepting Medicare

2 Speech-Language Pathologists found. Showing 1 - 2

Katie Rae Chandler, TSHH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 543 Robert Quigley Dr, Apt. 1, Scottsville, NY 14546 Phone: 607-972-7308

Mrs. Jennifer Leigh Wolford, B.S., S/L THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 387 Robert Quigley Dr, Scottsville, NY 14546 Phone: 585-469-6609

News Archive

Global wealth inequality threatens progress made in reducing child mortality, Save the Children report says

While progress has been made worldwide in reducing child mortality, the effects have been unequal across income groups, and wealth inequalities are at the highest level in 20 years and increasing, according to a report from Save the Children U.K., BBC News reports.

Global burden of disease shifts from infectious diseases to noncommunicable diseases

The global burden of disease is shifting from infectious diseases to noncommunicable diseases, with chronic conditions such as heart disease and stroke now being the chief causes of death globally, according to a new WHO report published today. The shifting health trends indicate that leading infectious diseases - diarrhoea, HIV, tuberculosis, neonatal infections and malaria - will become less important causes of death globally over the next 20 years.

Scientists identify novel strategy to treat pancreatic cancer

Researchers have found that a protein called SLC6A14 is overexpressed by several fold in pancreatic tumors taken from patients and in cancerous pancreatic cells lines compared with normal pancreatic tissue or normal pancreatic cells.

U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin

Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.

President Obama designates September 2010 as National Prostate Cancer Awareness Month

On August 31, President Barack Obama signed a presidential proclamation designating September 2010 as 'National Prostate Cancer Awareness Month," stating: "Until we find a cure for this disease, my Administration will continue promoting awareness of this illness and supporting prostate cancer research and treatment."

Read more Medical News

› Verified 8 days ago